NVCT logo

Nuvectis Pharma (NVCT) EBITDA

Annual EBITDA

-$19.85 M
+$3.05 M+13.32%

December 1, 2024


Summary


Performance

NVCT EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNVCTprofitabilitymetrics:

Quarterly EBITDA

-$6.45 M
-$2.09 M-47.95%

December 1, 2024


Summary


Performance

NVCT Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNVCTprofitabilitymetrics:

TTM EBITDA

-$19.85 M
+$417.00 K+2.06%

December 1, 2024


Summary


Performance

NVCT TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNVCTprofitabilitymetrics:

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

NVCT EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+13.3%0.0%0.0%
3 y3 years-53.9%-4.7%+13.0%
5 y5 years--4.7%+13.0%

NVCT EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-53.9%+13.3%-184.7%+6.1%-53.9%+14.4%
5 y5-year-53.9%+13.3%<-9999.0%+6.1%<-9999.0%+14.4%
alltimeall time-53.9%+13.3%<-9999.0%+6.1%<-9999.0%+14.4%

Nuvectis Pharma EBITDA History

DateAnnualQuarterlyTTM
Dec 2024
-$19.85 M(-13.3%)
-$6.45 M(+47.9%)
-$19.85 M(-2.1%)
Sep 2024
-
-$4.36 M(-6.1%)
-$20.26 M(-8.2%)
Jun 2024
-
-$4.64 M(+5.6%)
-$22.06 M(-4.9%)
Mar 2024
-
-$4.40 M(-36.0%)
-$23.19 M(+1.3%)
Dec 2023
-$22.90 M(+19.0%)
-$6.87 M(+11.5%)
-$22.90 M(+0.4%)
Sep 2023
-
-$6.16 M(+6.7%)
-$22.81 M(+1.0%)
Jun 2023
-
-$5.77 M(+40.7%)
-$22.59 M(+10.8%)
Mar 2023
-
-$4.10 M(-39.5%)
-$20.39 M(+6.0%)
DateAnnualQuarterlyTTM
Dec 2022
-$19.23 M(+49.2%)
-$6.78 M(+14.1%)
-$19.23 M(+30.7%)
Sep 2022
-
-$5.94 M(+66.2%)
-$14.72 M(+9.4%)
Jun 2022
-
-$3.57 M(+21.3%)
-$13.45 M(-15.0%)
Mar 2022
-
-$2.94 M(+30.0%)
-$15.82 M(+22.7%)
Dec 2021
-$12.89 M
-$2.27 M(-51.5%)
-$12.89 M(+21.3%)
Sep 2021
-
-$4.67 M(-21.4%)
-$10.63 M(+78.3%)
Jun 2021
-
-$5.94 M(>+9900.0%)
-$5.96 M(>+9900.0%)
Mar 2021
-
-$23.00 K
-$23.00 K

FAQ

  • What is Nuvectis Pharma annual EBITDA?
  • What is the all time high annual EBITDA for Nuvectis Pharma?
  • What is Nuvectis Pharma annual EBITDA year-on-year change?
  • What is Nuvectis Pharma quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Nuvectis Pharma?
  • What is Nuvectis Pharma quarterly EBITDA year-on-year change?
  • What is Nuvectis Pharma TTM EBITDA?
  • What is the all time high TTM EBITDA for Nuvectis Pharma?
  • What is Nuvectis Pharma TTM EBITDA year-on-year change?

What is Nuvectis Pharma annual EBITDA?

The current annual EBITDA of NVCT is -$19.85 M

What is the all time high annual EBITDA for Nuvectis Pharma?

Nuvectis Pharma all-time high annual EBITDA is -$12.89 M

What is Nuvectis Pharma annual EBITDA year-on-year change?

Over the past year, NVCT annual EBITDA has changed by +$3.05 M (+13.32%)

What is Nuvectis Pharma quarterly EBITDA?

The current quarterly EBITDA of NVCT is -$6.45 M

What is the all time high quarterly EBITDA for Nuvectis Pharma?

Nuvectis Pharma all-time high quarterly EBITDA is -$23.00 K

What is Nuvectis Pharma quarterly EBITDA year-on-year change?

Over the past year, NVCT quarterly EBITDA has changed by $0.00 (0.00%)

What is Nuvectis Pharma TTM EBITDA?

The current TTM EBITDA of NVCT is -$19.85 M

What is the all time high TTM EBITDA for Nuvectis Pharma?

Nuvectis Pharma all-time high TTM EBITDA is -$23.00 K

What is Nuvectis Pharma TTM EBITDA year-on-year change?

Over the past year, NVCT TTM EBITDA has changed by $0.00 (0.00%)